For a better experience, click the Compatibility Mode icon above to turn off Compatibility Mode, which is only for viewing older websites.

Promoting Innovation Through Collaboration

Research and training focused on diagnosis, treatment, prevention and clinical management of infectious disease, cancer, and metabolic and genetic disorders.

The Drexel University College of Medicine Institute for Molecular Medicine and Infectious Disease is a collaborative inter-campus enterprise focused on research, diagnosis, treatment, prevention, and clinical management of infectious disease, cancer, and metabolic and genetic disorders.

The institute guides the development of collaborative research programs that will be competitive for extramural research and training support. The institute also provides an organized framework to guide the development of inter-campus, inter-college and inter-unit research initiatives across the College.


Upcoming and Recent Events

2017 Research Seminar Schedule
 


 
News and Announcements
 

Dr. Ehrlich Gives Keynote Address

Garth Ehrlich, PhD, professor of microbiology and immunology, presented the keynote lecture at the 8th International Conference on Emerging Zoonoses, Manhattan, Kansas, on May 8, 2017. His talk was titled "Toward Re-Potentiating Antibiotics Against Bacterial Biofilms and Persisters Through an Understanding of Bacterial Physiology."

Dr. Ehrlich presenting his keynote lecture
Dr. Ehrlich presenting his keynote lecture.


Sean F. Bradley, PhD, presents his research.

Sean F. Bradley, PhD, presents his research.

"Natural Products From Uncultured Bacteria"

On Wednesday, March 29, Joris Beld, PhD, hosted Sean F. Bradley, PhD, Howard Hughes Medical Institute, Tri-Institutional Associate Professor, Head of the Laboratory of Genetically Encoded Small Molecules, The Rockefeller University. Dr. Brady’s research interests center on both the discovery and the functional characterization of new small molecules from previously inaccessible genetic sources. His presentation at the IMMID research seminar was called "Natural products from uncultured bacteria." Learn more about Dr. Brady and his lab.


Genomics Reveal How Bacteria Evolve in Cystic Fibrosis Patients

Scientists have made new headway in understanding how a deadly pathogen evolves during chronic lung infections in cystic fibrosis patients. "By looking at changes in the genome over time, we were able to see patterns — common themes that help us to better understand how this particular species evolves in its environment and how CF patients become chronically infected," said study co-corresponding author Joshua Chang Mell, PhD, an assistant professor at Drexel University College of Medicine. Drexel Now (March 21, 2017)

See all news

 
 Back to Top

Brian Wigdahl, PhD

Brian Wigdahl, PhD
Director, Institute for Molecular Medicine & Infectious Disease